The Role of Thromboelastography in Directing Blood Product Usage in Infant Open Heart Surgery

Objective Thromboelastography (TEG) measures the dynamics of clot formation in whole blood and provides data that can guide specific blood component therapy. This study analyzed whether the implementation of TEG affected blood product utilization and overall hemostasis in infants (6 months and younger) undergoing open heart surgery. Methods TEG values measured include R (time to fibrin formation), angle (fibrinogen formation), and MA (platelet function). Blood product usage, TEG values, and operative parameters were collected during surgery on 112 consecutive infants (66 acyanotic) undergoing open heart surgery within the first 6 months of life. Controls consisted of chart data on 70 consecutive patients (57 acyanotic) undergoing the same surgical procedures before implementation of TEG (pre-TEG). Results Using TEG, the pattern of blood product utilization changed. Compared with the pre-TEG era, TEG era patients demonstrated a significant increase in fresh frozen plasma usage intraoperatively (4.74 vs. 1.83 mL/kg; P < 0.001) and reduced postoperative use of platelets (1.69 vs. 3.74 mL/kg; P = 0.006) and cryoprecipitate (0.89 vs. 1.95 mL/kg; P = 0.149). Chest tube drainage was significantly reduced at 1, 2, and 24 hours in the TEG group. TEG angle and MA measurements suggest that fibrinogen and platelets of cyanotic patients are more sensitive to hemodilution than the acyanotic patients. Conclusions TEG allows for proactive, goal-directed blood component therapy with improved postoperative hemostasis in infants undergoing cardiopulmonary bypass.

[1]  J. Jaggers,et al.  Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies. , 2006, The Annals of thoracic surgery.

[2]  Jennifer L Miller,et al.  Fibrinogen in Children Undergoing Cardiac Surgery: Is It Effective? , 2004, Anesthesia and analgesia.

[3]  M. Zimpfer,et al.  Heparinase-Modified Thrombelastography in Term and Preterm Neonates , 2004, Anesthesia and analgesia.

[4]  M. DePerio,et al.  Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. , 1999, Anesthesia and analgesia.

[5]  S. Bratton,et al.  Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. , 1998, Journal of cardiothoracic and vascular anesthesia.

[6]  S. Bratton,et al.  Association between age and blood loss in children undergoing open heart operations. , 1998, The Annals of thoracic surgery.

[7]  K. Kanter,et al.  Predicting and Treating Coagulopathies After Cardiopulmonary Bypass in Children , 1997, Anesthesia and analgesia.

[8]  G. W. Holbrook,et al.  Functional Maturity of the Coagulation System in Children: An Evaluation Using Thrombelastography , 1997, Anesthesia and analgesia.

[9]  G. Rivard,et al.  Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. , 1996, The Annals of thoracic surgery.

[10]  A. Michelson,et al.  Neonatal Platelets Are Less Reactive than Adult Platelets to Physiological Agonists in Whole Blood , 1994, Thrombosis and Haemostasis.

[11]  Boscoe M. Paes,et al.  Development of the Hemostatic System in the Neonate and Young Infant , 1990, The American journal of pediatric hematology/oncology.

[12]  Boscoe M. Paes,et al.  Development of the human coagulation system in the healthy premature infant. , 1988, Blood.

[13]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[14]  J. Caprini,et al.  Comparison of Thrombelastography with Common Coagulation Tests , 1981, Thrombosis and Haemostasis.